ATE260117T1 - Pharmazeutische zusammensetzung zur behandlung von parkinsonkrankheit oder depression - Google Patents

Pharmazeutische zusammensetzung zur behandlung von parkinsonkrankheit oder depression

Info

Publication number: ATE260117T1
Authority: AT; Austria
Prior art keywords: depression; disease; pharmaceutical composition; treating parkinson; vitamin
Prior art date: 1997-01-28

Application number

AT98901388T

Other languages

English (en)

Inventor

Keith Bridgeman

Original Assignee

Keith Bridgeman

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-28

Filing date

1998-01-27

Publication date

2004-03-15

1998-01-27 Application filed by Keith Bridgeman filed Critical Keith Bridgeman

2004-03-15 Application granted granted Critical

2004-03-15 Publication of ATE260117T1 publication Critical patent/ATE260117T1/de

Links

208000018737 Parkinson disease Diseases 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 4
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 3
DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 3
-1 pyridoxine) Chemical compound 0.000 abstract 3
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
235000019152 folic acid Nutrition 0.000 abstract 2
239000011724 folic acid Substances 0.000 abstract 2
229940011671 vitamin b6 Drugs 0.000 abstract 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 1
229930003537 Vitamin B3 Natural products 0.000 abstract 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
230000009471 action Effects 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
229960003638 dopamine Drugs 0.000 abstract 1
229940014144 folate Drugs 0.000 abstract 1
229960000304 folic acid Drugs 0.000 abstract 1
229910052742 iron Inorganic materials 0.000 abstract 1
229960003966 nicotinamide Drugs 0.000 abstract 1
235000005152 nicotinamide Nutrition 0.000 abstract 1
239000011570 nicotinamide Substances 0.000 abstract 1
229960003512 nicotinic acid Drugs 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
229940127557 pharmaceutical product Drugs 0.000 abstract 1
RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
235000008160 pyridoxine Nutrition 0.000 abstract 1
239000011677 pyridoxine Substances 0.000 abstract 1
230000028327 secretion Effects 0.000 abstract 1
230000032258 transport Effects 0.000 abstract 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
235000019160 vitamin B3 Nutrition 0.000 abstract 1
239000011708 vitamin B3 Substances 0.000 abstract 1
235000019158 vitamin B6 Nutrition 0.000 abstract 1
239000011726 vitamin B6 Substances 0.000 abstract 1
239000011701 zinc Substances 0.000 abstract 1
229910052725 zinc Inorganic materials 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Psychology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AT98901388T 1997-01-28 1998-01-27 Pharmazeutische zusammensetzung zur behandlung von parkinsonkrankheit oder depression ATE260117T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9701675.2A GB9701675D0 (en)	1997-01-28	1997-01-28	Composition for the treatment of parkinson's disease
PCT/GB1998/000229 WO1998032464A1 (en)	1997-01-28	1998-01-27	Pharmaceutical composition comprising at least tyrosine and an iron compound for treating parkinson's disease or depression

Publications (1)

Publication Number	Publication Date
ATE260117T1 true ATE260117T1 (de)	2004-03-15

Family

ID=10806668

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98901388T ATE260117T1 (de)	1997-01-28	1998-01-27	Pharmazeutische zusammensetzung zur behandlung von parkinsonkrankheit oder depression

Country Status (9)

Country	Link
US (1)	US6200607B1 (de)
EP (1)	EP0980260B1 (de)
AT (1)	ATE260117T1 (de)
AU (1)	AU741511B2 (de)
DE (1)	DE69821929T2 (de)
ES (1)	ES2217534T3 (de)
GB (1)	GB9701675D0 (de)
WO (1)	WO1998032464A1 (de)
ZA (1)	ZA98687B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6476078B2 (en) *	1999-08-11	2002-11-05	Sepracor, Inc.	Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
ES2187115T3 (es) *	1999-01-20	2003-05-16	Nutricia Nv	Preparado para lactantes.
US7226916B1 (en) *	2000-05-08	2007-06-05	N.V. Nutricia	Preparation for the prevention and/or treatment of vascular disorders
US7208180B2 (en) *	2000-05-08	2007-04-24	N.V. Nutricia	Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
US6620850B2 (en) *	2001-09-19	2003-09-16	University Of Florida	Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors
US20050065205A1 (en)	2002-03-07	2005-03-24	Daniel Alkon	Methods for Alzheimer's disease treatment and cognitive enhance
US6825229B2 (en)	2002-03-07	2004-11-30	Blanchette Rockefeller Neurosciences Institute	Methods for Alzheimer's Disease treatment and cognitive enhancement
GB0313630D0 (en) *	2003-06-12	2003-07-16	Wwk Trust The	Compositions for the enhanced treatment of depression
TW201206425A (en) *	2004-05-18	2012-02-16	Brni Neurosciences Inst	Treatment of depressive disorders
US20070054890A1 (en)	2005-07-29	2007-03-08	Alkon Daniel L	Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning
US8367121B2 (en) *	2005-11-23	2013-02-05	Florida A & M University	Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease
EP3332797A3 (de)	2007-02-09	2018-08-01	Blanchette Rockefeller Neurosciences Institute	Therapeutische wirkungen von bryostatinen, bryologen und anderen damit zusammenhängenden substanzen auf durch kopftraumata herbeigeführte gedächtnisstörungen und hirnverletzungen
JP5098051B2 (ja)	2007-04-05	2012-12-12	Ｓｂｉファーマ株式会社	ミトコンドリア障害脳疾患治療剤及び診断剤
US9463186B2 (en)	2013-04-15	2016-10-11	Northwestern University	Treatment for dopaminergic disorders
EP3431491A1 (de) *	2017-07-18	2019-01-23	Centre National De La Recherche Scientifique	Verfahren zur reinigung von proteinen mit einer tubulin-carboxypeptidase-aktivität und peptidbasierten inhibitoren davon
US11690849B2 (en)	2019-04-12	2023-07-04	LA PharmaTech Inc.	Method of treating dementia
US11744833B2 (en)	2019-04-12	2023-09-05	LA PharmaTech Inc.	Pharmaceutical compositions and methods for treatment of insomnia
US11351179B1 (en)	2021-08-05	2022-06-07	LA PharmaTech Inc.	Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4167564A (en) *	1974-09-23	1979-09-11	Albion Laboratories, Inc.	Biological assimilation of metals
JPS58162515A (ja) *	1982-03-19	1983-09-27	Tanabe Seiyaku Co Ltd	末梢静脈注入用加電解質アミノ酸輸液
RO94381B1 (ro) *	1986-04-28	1988-05-01	Valentin Stroescu	Produs medicamentos pentru sustinerea efortului de durata medie si lunga
FR2617711B1 (fr) *	1987-07-09	1991-01-04	Mouret Jacques	Application de la l-tyrosine pour l'obtention de medicaments destines au traitement des deficits en dopamine dans les narcolepsies et les depressions dopamino-dependantes
US5122461A (en) *	1990-11-19	1992-06-16	Industrial Technology Research Institute	Preparation of pyrocatecholic compounds
GB2268871A (en) *	1992-07-04	1994-01-26	Bio Nutritional Health Service	Composition for use as a food or food supplement
JPH07330583A (ja) *	1994-06-03	1995-12-19	Terumo Corp	遊離型グルタミン酸を含有する液状製剤
GB9416921D0 (en) *	1994-08-22	1994-10-12	Conway Gitta C	A nutritional preparation

1997
- 1997-01-28 GB GBGB9701675.2A patent/GB9701675D0/en active Pending
1998
- 1998-01-27 EP EP98901388A patent/EP0980260B1/de not_active Expired - Lifetime
- 1998-01-27 AT AT98901388T patent/ATE260117T1/de not_active IP Right Cessation
- 1998-01-27 AU AU57725/98A patent/AU741511B2/en not_active Ceased
- 1998-01-27 DE DE69821929T patent/DE69821929T2/de not_active Expired - Lifetime
- 1998-01-27 ES ES98901388T patent/ES2217534T3/es not_active Expired - Lifetime
- 1998-01-27 WO PCT/GB1998/000229 patent/WO1998032464A1/en not_active Ceased
- 1998-01-27 US US09/367,851 patent/US6200607B1/en not_active Expired - Lifetime
- 1998-01-28 ZA ZA98687A patent/ZA98687B/xx unknown

Also Published As

Publication number	Publication date
WO1998032464A1 (en)	1998-07-30
AU741511B2 (en)	2001-12-06
US6200607B1 (en)	2001-03-13
ES2217534T3 (es)	2004-11-01
DE69821929D1 (de)	2004-04-01
ZA98687B (en)	1998-09-08
EP0980260A1 (de)	2000-02-23
AU5772598A (en)	1998-08-18
GB9701675D0 (en)	1997-03-19
EP0980260B1 (de)	2004-02-25
DE69821929T2 (de)	2004-11-11

Legal Events

Date	Code	Title	Description
2004-08-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69821929D1 (de)	2004-04-01	Pharmazeutische zusammensetzung zur behandlung von parkinsonkrankheit oder depression
IS1907B (is)	2003-12-16	Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
ATE348829T1 (de)	2007-01-15	Pharmazeutische zusammensetzungen zur behandlung von störungen des zns oder anderen erkrankungen
MXPA03003960A (es)	2004-09-10	Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
DE60134453D1 (de)	2008-07-31	Pharmazeutische Zusammensetzungen zur Behandlung von ZNS und anderen Krankheiten
ATE168560T1 (de)	1998-08-15	Topische mittel zur transdermalen verabreichung von prodrugderivaten des morphins
WO2003076003A3 (en)	2003-11-13	Method for modification of radiotherapy treatment delivery
DK0830377T4 (da)	2013-03-11	Glucagon-lignende peptid-2 og terapeutisk anvendelse deraf
NO960067L (no)	1996-01-05	Nytt farmasöytisk preparat
IL144144A0 (en)	2002-05-23	Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
IT1222395B (it)	1990-09-05	Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare
BG105275A (en)	2001-11-30	Tan-1057 derivatives
PL367089A1 (en)	2005-02-21	Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia
WO2003009835A3 (en)	2003-08-07	Novel use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
MY130445A (en)	2007-06-29	Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
MY136976A (en)	2008-12-31	Novel use of (r)-(-)-2-[5-(4- flourophenyl) -3-pyridylmethylaminomethyl]- chromane and its physiologically acceptable salts
DE60037402D1 (de)	2008-01-24	Behandlung von autoimmunkrankheiten mit einem extrakt von amerikanischem ginseng
ATE147988T1 (de)	1997-02-15	Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände
ATE404519T1 (de)	2008-08-15	Hyperforinderivate, ihre verwendung sowie diese enthaltende zubereitungen
IL160160A0 (en)	2004-07-25	SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS
HRP20070271T3 (en)	2007-07-31	Use of follicle stimulating hormone for reduction of spermatozoa chromosomal aberration in males
YU17002A (sh)	2004-11-25	Upotreba deksrazoksana u lečenju psorijaze
GEP20033135B (en)	2003-12-25	Means for Treatment of Fungoid Diseases